Status:
UNKNOWN
Influence of COVID-19 on Vascular Endothelial Function
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Bernhoven Hospital
Conditions:
COVID
Vascular; Damage
Eligibility:
All Genders
16+ years
Brief Summary
Rationale: Infection with severe acute respiratory syndrome coronavirus (SARS-CoV) 2 could result in endothelial dysfunction with increased risk of arterial thrombotic events by downregulating the exp...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV2 infection by polymerase chain reaction on nasopharyngeal swab, sputum or bronchoalveolar lavage.
- At least 6 and no more than 20 weeks after resolution of COVID-19 related symptoms
- ≥ 16 years old
Exclusion
- Recent (\<3 months) angina pectoris, myocardial infarction, stroke, or heart failure
- Raynaud syndrome, scleroderma, complex regional pain syndrome of the upper extremity or presence of arteriovenous fistula or open wounds on both the upper extremities.
Key Trial Info
Start Date :
July 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT04468412
Start Date
July 14 2020
End Date
March 30 2022
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bernhoven
Uden, Netherlands, 5406 PT